Business Context and Reporting Period
This Form 8-K is a current report filed by iBio, Inc. on October 18, 2017. The filing addresses corporate governance matters regarding the scheduling of the company's 2017 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.
Material Changes
The Board of Directors advanced the date of the 2017 Annual Meeting of Stockholders to Tuesday, December 19, 2017. This date is more than 30 days prior to the anniversary of the 2016 Annual Meeting, triggering a requirement under Rule 14a-5(f) to notify stockholders of the change.
Guidance, Outlook, and Corporate Actions
- Record Date: Stockholders of record as of the close of business on November 16, 2017, are entitled to vote at the 2017 Annual Meeting.
- Proposal Deadlines: Due to the date change, a new deadline was established for stockholder proposals. Proposals intended for inclusion in the proxy statement under Rule 14a-8, as well as nominations for director elections or other business under the Company's Bylaws, must be received by the Company Secretary by the close of business on November 2, 2017.
- Meeting Details: The specific time and location of the meeting will be detailed in the Company's proxy statement.
Key Facts for Investor Verification
- Verify the record date of November 16, 2017, to determine voting eligibility.
- Note the November 2, 2017, deadline for submitting shareholder proposals or director nominations.
- Confirm the final time and location of the Annual Meeting once the proxy statement is released.
- Review the Company's Bylaws for specific requirements regarding the content of proposals submitted outside of Rule 14a-8.